5 completed, 4 unknown, 3 terminated, 1 enrolling by invitation. 14 Phase 1, 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 14 | Completed 5, Unknown 4, Terminated 3, Enrolling by invitation 1, Recruiting 1 |
| Phase 2 | 7 | Completed 3, Unknown 2, Enrolling by invitation 1, Recruiting 1 |
Follow Liver Transplantation: new trials by email Literature Review of Liver Transplantation trials Research Report on Liver Transplantation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immune Tolerance Induction After Liver Transplantation Donor Hematopoietic Stem and Progenitor Cell Infusion - Liver Transplantation, Immune Tolerance | Phase 1 / Phase 2 | Recruiting | University of California, Los Angeles | 12 | 2026-02-20 | 2026-03-12 |
| Secretin in Ex-situ Liver Perfusion Secretin administration during ex-situ liver machine perfusion - Liver Transplantation | Phase 1 / Phase 2 | Enrolling by invitation | Erasmus Medical Center | 20 | 2025-04-26 | 2026-06-16 |
| Safety and Efficacy of Camrelizumab (Anti-PD-1 Antibody) in Recurrent HCC After Liver Transplantation Camrelizumab treatment - Hepatocellular Carcinoma, Liver Transplantation | Phase 1 | Unknown | Third Affiliated Hospital, Sun Yat-Sen University | 20 | 2020-09-21 | 2022-05-03 |
| Safety and Efficacy of PD-1 Inhibitors in Patients With Liver Transplant JS001(PD-1 inhibitor) - Hepatocellular Carcinoma, Liver Transplantation | Phase 1 | Unknown | Shanghai Zhongshan Hospital | 20 | 2019-05-01 | 2019-05-31 |
| Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation Immuncell-LC - Liver Transplantation | Phase 1 / Phase 2 | Completed | GC Cell Corporation | 19 | 2019-01-24 | 2023-06-22 |
| Post Static Cold Storage Normothermic Machine Liver Perfusion Normothermic Machine Liver Perfusion - Liver Transplantation | Phase 1 / Phase 2 | Unknown | University of Oxford | 30 | 2017-05-01 | 2017-06-05 |
| Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation Anti-Thymocyte Globulin - Rabbit, darTreg Infusion, Everolimus - Liver Transplantation | Phase 1 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 15 | 2014-12-17 | 2020-09-22 |
| Therapeutic Strategy and the Role of Mesenchymal Stromal Cells for ABO Incompatible Liver Transplantation Mesenchymal Stem Cells(MSCs) - Liver Transplantation | Phase 1 / Phase 2 | Unknown | Third Affiliated Hospital, Sun Yat-Sen University | 15 | 2014-02-01 | 2016-03-11 |
| Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression. Extracorporeal Photopheresis Procedure (FEC) - Liver Transplantation, Immunosuppression | Phase 1 / Phase 2 | Completed | Red de Terapia Celular | 10 | 2013-04-01 | 2017-03-30 |
| Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantation MultiStem - Liver Transplantation | Phase 1 | Terminated | Prof. Dr. Marc-H. Dahlke, Ph. D. | 3 | 2013-04-01 | 2018-08-17 |
| A Multicenter Study Evaluating the Safety and Tolerability of Intravenous rhMBL in Liver Transplant Recipients. Intravenous Recombinant Human Mannose-Binding Lectin (rhMBL) - Liver Transplantation | Phase 1 | Terminated | Enzon Pharmaceuticals, Inc. | 24 | 2006-12-01 | 2011-08-09 |
| Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients Immunosuppression Withdrawal - Liver Transplant, Liver Transplantation | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 20 | 2006-06-05 | 2018-09-20 |
| Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver Adefovir dipivoxil and hepatitis B vaccination - Hepatitis B, Liver Transplantation | Phase 1 / Phase 2 | Completed | Columbia University | 16 | 2006-03-01 | 2021-08-10 |
| Vasosol Organ Perfusion Solution and Medtronic Portable Bypass System Vasosol Organ Perfusion Solution and Medtronic Portable Bypass System - Liver Transplantation, Organ Preservation | Phase 1 | Completed | Polyak, Maximilian | 20 | 2004-07-01 | 2009-04-09 |
Carcinoma, Hepatocellular (2) · End Stage Liver Disease (1) · Hepatitis B (1)
Digestive System Diseases (4) · Liver Diseases (4) · Adenocarcinoma (2) · Carcinoma (2) · Digestive System Neoplasms (2) · Liver Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Blood-Borne Infections (1) · Communicable Diseases (1) · DNA Virus Infections (1) · Hepadnaviridae Infections (1) · Hepatic Insufficiency (1)
Acetaminophen (1) · Antilymphocyte Serum (1) · Blood Specimen Collection (1) · Diphenhydramine (1) · Everolimus (1) · FEC protocol (1) · Ganciclovir (1) · Leukapheresis (1) · Liver Transplantation (1) · Methylprednisolone Hemisuccinate (1) · Mycophenolic Acid (1) · Phlebotomy (1) · Prednisone (1) · Tacrolimus (1) · Valganciclovir (1)
National Institute of Allergy and Infectious Diseases (NIAID) (2) · Third Affiliated Hospital, Sun Yat-Sen University (2) · Columbia University (1) · Enzon Pharmaceuticals, Inc. (1) · Erasmus Medical Center (1) · GC Cell Corporation (1) · Polyak, Maximilian (1) · Prof. Dr. Marc-H. Dahlke, Ph. D. (1) · Red de Terapia Celular (1) · Shanghai Zhongshan Hospital (1) · University of California, Los Angeles (1) · University of Oxford (1)
United States (5) · China (3) · Germany (1) · Netherlands (1) · South Korea (1) · Spain (1) · United Kingdom (1)
Alison Freifeld, MD (1) · Cray V. Noah, MD (1) · James V. Guarrera, M.D. (1) · Jeffrey Bluestone, PhD (1) · Jeffrey Veale, MD (1) · Kyung Suk Suh, MD (1) · Peter Friend (1) · Qizhi Tang, PhD (1) · Robert J Porte, MD, PhD (1) · Robert S Brown, Jr, MD, MPH (1) · Sandy Feng, MD (1) · Sandy Feng, MD, PhD (1) · Sang-Mo Kang, MD, FACS (1) · Yang Yang (1)
PMID 22253395, PMID 25648649, PMID 27302659
2009 (1), R34AI095135 (1), U01AI110658 (1)